Kesavan Srikumar has joined pharmacy automation provider PerceptiMed Inc. as senior director of manufacturing. PerceptiMed noted that Srikumar brings more than 30 years of manufacturing experience to the company. Previously, he held management positions at Solectron, Flextronics and Aviat Networks.
Following through on pledge made this summer, President Donald Trump has formally declared the nation’s growing opioid abuse epidemic as a public health emergency.
The National Association of Chain Drug Stores, National Community Pharmacists Association and Washington State Pharmacy Association (WSPA) are challenging changes to Medicaid pharmacy reimbursement in Washington state.
CVS Health has officially expanded its safe medication disposal kiosk program to CVS Pharmacy stores.
For its CVS Caremark pharmacy benefit manager, CVS Health next year plans to roll out a new 30,000-store pharmacy network anchored by CVS Pharmacy and Walgreens. CVS said late Tuesday that the performance-based network also will include up to 10,000 independent community pharmacies nationwide.
Early next year, AstraZeneca plans to release Bydureon BCise, a new formulation of Bydureon (exenatide extended-release) injectable suspension in an improved once-weekly, single-dose autoinjector for adults with type 2 diabetes.
The National Association of Chain Drug Stores has made four policy proposals to help fight opioid abuse in a letter to President Donald Trump.
Walgreens is now carrying Adapt Pharma’s Narcan, a nasal spray form of opioid overdose antidote naloxone, in all of its more than 8,000 pharmacies nationwide.
McKesson U.S. Pharmaceutical president Mark Walchirk is leaving the company to become president and chief executive officer of Patterson Companies Inc., a distributor serving the dental and animal health markets. Patterson said Tuesday that Walchirk is slated to start at the company on Nov. 20.
Rite Aid Corp. has begun offering assistance to seniors during the Medicare Part D open enrollment period. Through Dec.
Janssen Biotech Inc. has gained Food and Drug Administration approval for Simponi Aria (golimumab) to treat adults with active psoriatic arthritis or active ankylosing spondylitis.
Next week, Brenda Raphael is slated to take the reins as senior vice president and general manager of the therapeutics business unit of Bayer Consumer Health commercial operations for North America.
McKesson Corp. chairman and chief executive officer John Hammergren has endorsed President Donald Trump’s plan to designate the opioid abuse crisis as a national emergency.
After numerous failed attempts to repeal the Affordable Care Act, President Donald Trump has signed an executive order to relax standards on small businesses that band together to buy health insurance and may take steps to allow the sale of other health plans that skirt the health law’s requirements
Canada is making strides in the deployment of its national e-prescribing service, PrescribeIT.
Sunovion Pharmaceuticals Inc. has released Seebri Neohaler Inhalation Powder (glycopyrrolate 15.6 mcg), a treatment for chronic obstructive pulmonary disease (COPD), to U.S. pharmacies. Sunovion said Thursday that it entered into an exclusive license agreement with Novartis for the U.S.
